These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7190711)

  • 21. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of dopamine antagonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
    Yamada S; Takaki T; Yokoo H; Tanaka M
    J Pharm Pharmacol; 1995 Mar; 47(3):259-62. PubMed ID: 7602493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite effects of D-amphetamine on spontaneous neuronal activity in the neostriatum and nucleus accumbens.
    Rebec GV; Zimmerman KS
    Brain Res; 1980 Nov; 201(2):485-91. PubMed ID: 7191347
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.
    Mayfield RD; Larson G; Zahniser NR
    Brain Res; 1992 Feb; 573(2):331-5. PubMed ID: 1387030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
    Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
    Spano PF; Trabucchi M
    Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M; Lovenberg W; Hanbauer I
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4456-60. PubMed ID: 6956874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypotheses of different dopamine receptor mechanisms.
    Costall B; Naylor RJ
    Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
    [No Abstract]   [Full Text] [Related]  

  • 35. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 36. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M; Battaini F; Spano PF; Trabucchi M
    Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E
    Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC; Onali P
    Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.